Literature DB >> 1003702

Pharmacological studies on root bark of mulberry tree (Morus alba L.)

Y Yamatake, M Shibata, M Nagai.   

Abstract

Pharmacological studies were done on the root bark of mulberry tree and pharmacological effects were compared with the clinical effects of "Sohakuhi" in Chinese medicine. n-Butanol- and water-soluble fractions of mulberry root had similar effects except for those on the cadiovascular system. Both fractions showed cathartic, analgesic, diuretic, antitussive, antiedema, sedative, anticonvulsant, and hypotensive actions in mice, rats, guinea pigs and dogs. There appears to be a correlation between the experimental pharmacological results and the clinical applications of mulberry root found in the literature on Chinese medicine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003702     DOI: 10.1254/jjp.26.461

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  The Effects of Morus alba and Acacia catechu on Quality of Life and Overall Function in Adults with Osteoarthritis of the Knee.

Authors:  Douglas S Kalman; Susan J Hewlings
Journal:  J Nutr Metab       Date:  2017-09-11

2.  Vascular Protection by Ethanol Extract of Morus alba Root Bark: Endothelium-Dependent Relaxation of Rat Aorta and Decrease of Smooth Muscle Cell Migration and Proliferation.

Authors:  Nisha Panth; Keshav Raj Paudel; Dal-Seong Gong; Min-Ho Oak
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-01       Impact factor: 2.629

3.  Insight into the PTP1B Inhibitory Activity of Arylbenzofurans: An In Vitro and In Silico Study.

Authors:  Srijan Shrestha; Su Hui Seong; Seul Gi Park; Byung Sun Min; Hyun Ah Jung; Jae Sue Choi
Journal:  Molecules       Date:  2019-08-09       Impact factor: 4.411

4.  JNK1/2 Activation by an Extract from the Roots of Morus alba L. Reduces the Viability of Multidrug-Resistant MCF-7/Dox Cells by Inhibiting YB-1-Dependent MDR1 Expression.

Authors:  Youn Kyung Choi; Sung-Gook Cho; Hyeong Sim Choi; Sang-Mi Woo; Yee Jin Yun; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-24       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.